Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older at the time of signing the consent form.
- A doctor at a UCI-affiliated clinic suspects you may have muscle-invasive bladder cancer based on what they saw during a routine camera examination of your bladder (cystoscopy).
- You are generally able to carry out some daily activities, even if limited — your overall health and activity level falls within an acceptable range as assessed by the study team (ECOG score 0–3).
- You are able to understand the study information and are willing to sign a consent form before the study begins.
- You are willing and able to attend all required visits, scans, follow-up appointments, and other study-related activities as agreed with the study team.
Who may not be able to join:
- You have had a surgical procedure to remove bladder tumor tissue (TURBT) within the last 120 days.
- You have received any treatment for bladder cancer within the last 180 days.
- You are unable to have a specialised type of MRI scan (mpMRI) or cannot tolerate the dye used during the scan.
- You are unable to have the bladder tumor removal procedure (TURBT) or cannot tolerate the anaesthesia used during it.
- Your overall health and activity level is very severely limited (ECOG score of 4).
- You are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nataliya Mar, MD, Chao Family Comprehensive Cancer Center
Phone: 1-877-827-8839
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of concordance between VI-RADS score of 4 or 5 (i.e. muscular propria is likely or very likely) on mpMRI and pathologic muscularis propria invasion (i.e. pT2 tumor stage) on diagnostic TURBT.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.